Raymond James & Associates Vbi Vaccines Inc Call Options Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $83,808 - $124,416	-28,800 Reduced 42.23%	39,400 $13,000
Q4 2020 Feb 12, 2021	SELL	$2.15 - $3.5 $68,800 - $112,000	-32,000 Reduced 31.94%	68,200 $31,000
Q3 2020 Nov 04, 2020	BUY	$2.77 - $6.17 $172,294 - $383,774	62,200 Added 163.68%	100,200 $48,000
Q2 2020 Jul 28, 2020	BUY	$0.87 - $3.13 $33,060 - $118,940	38,000 New	38,000 $44,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.